This is consistent with previous reports describing non-specific interactions between HY and viral envelopes or envelope proteins, where the compound showed activity against enveloped viruses but not against non-enveloped ones such as adenovirus or poliovirus [56] (iii) In the post-infection treatment, HY was added after viral entry into host cells. The gene discussed is ERVW-1; the disease is infection.